Table of Contents

2019-2024 Global Plerixafor Market Report (Status and Outlook)

1 Scope of the Report

• 1.1 Market Introduction
• 1.2 Research Objectives
• 1.3 Years Considered
• 1.4 Market Research Methodology
• 1.5 Economic Indicators
• 1.6 Currency Considered

2 Executive Summary

• 2.1 World Market Overview
  • 2.1.1 Global Plerixafor Market Size 2014-2024
  • 2.1.2 Plerixafor Market Size CAGR by Region
• 2.2 Plerixafor Segment by Type
  • 2.2.1 24MG/1.2ML
  • 2.2.2 Type II
• 2.3 Plerixafor Market Size by Type
  • 2.3.1 Global Plerixafor Market Size Market Share by Type (2014-2019)
  • 2.3.2 Global Plerixafor Market Size Growth Rate by Type (2014-2019)
• 2.4 Plerixafor Segment by Application
  • 2.4.1 Non-Hodgkin's lymphoma (NHL) Patients
  • 2.4.2 Multiple myeloma (MM) Patients
• 2.5 Plerixafor Market Size by Application
  • 2.5.1 Global Plerixafor Market Size Market Share by Application (2014-2019)
  • 2.5.2 Global Plerixafor Market Size Growth Rate by Application (2014-2019)

3 Global Plerixafor by Players

• 3.1 Global Plerixafor Market Size Market Share by Players
  • 3.1.1 Global Plerixafor Market Size by Players (2017-2019)
  • 3.1.2 Global Plerixafor Market Size Market Share by Players (2017-2019)
• 3.2 Global Plerixafor Key Players Head office and Products Offered
• 3.3 Market Concentration Rate Analysis
  • 3.3.1 Competition Landscape Analysis
  • 3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
• 3.4 New Products and Potential Entrants
• 3.5 Mergers & Acquisitions, Expansion

4 Plerixafor by Regions

• 4.1 Plerixafor Market Size by Regions
• 4.2 Americas Plerixafor Market Size Growth
• 4.3 APAC Plerixafor Market Size Growth
• 4.4 Europe Plerixafor Market Size Growth
• 4.5 Middle East & Africa Plerixafor Market Size Growth

5 Americas

• 5.1 Americas Plerixafor Market Size by Countries
• 5.2 Americas Plerixafor Market Size by Type
• 5.3 Americas Plerixafor Market Size by Application
• 5.4 United States
• 5.5 Canada
• 5.6 Mexico
• 5.7 Key Economic Indicators of Few Americas Countries

6 APAC

• 6.1 APAC Plerixafor Market Size by Countries
• 6.2 APAC Plerixafor Market Size by Type
• 6.3 APAC Plerixafor Market Size by Application
• 6.4 China
• 6.5 Japan
• 6.6 Korea
• 6.7 Southeast Asia
• 6.8 India
• 6.9 Australia
• 6.10 Key Economic Indicators of Few APAC Countries

7 Europe

• 7.1 Europe Plerixafor by Countries
• 7.2 Europe Plerixafor Market Size by Type
• 7.3 Europe Plerixafor Market Size by Application
• 7.4 Germany
• 7.5 France
• 7.6 UK
• 7.7 Italy
• 7.8 Russia
• 7.9 Spain
• 7.10 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa

• 8.1 Middle East & Africa Plerixafor by Countries
• 8.2 Middle East & Africa Plerixafor Market Size by Type
• 8.3 Middle East & Africa Plerixafor Market Size by Application
• 8.4 Egypt
• 8.5 South Africa
• 8.6 Israel
• 8.7 Turkey
• 8.8 GCC Countries

9 Market Drivers, Challenges and Trends

• 9.1 Market Drivers and Impact
  • 9.1.1 Growing Demand from Key Regions
  • 9.1.2 Growing Demand from Key Applications and Potential Industries
• 9.2 Market Challenges and Impact
• 9.3 Market Trends

10 Global Plerixafor Market Forecast

• 10.1 Global Plerixafor Market Size Forecast (2019-2024)
• 10.2 Global Plerixafor Forecast by Regions
  • 10.2.1 Global Plerixafor Forecast by Regions (2019-2024)
  • 10.2.2 Americas Market Forecast
  • 10.2.3 APAC Market Forecast
  • 10.2.4 Europe Market Forecast
  • 10.2.5 Middle East & Africa Market Forecast
• 10.3 Americas Forecast by Countries
  • 10.3.1 United States Market Forecast
  • 10.3.2 Canada Market Forecast
  • 10.3.3 Mexico Market Forecast
  • 10.3.4 Brazil Market Forecast
• 10.4 APAC Forecast by Countries
  • 10.4.1 China Market Forecast
  • 10.4.2 Japan Market Forecast
  • 10.4.3 Korea Market Forecast
  • 10.4.4 Southeast Asia Market Forecast
  • 10.4.5 India Market Forecast
  • 10.4.6 Australia Market Forecast
• 10.5 Europe Forecast by Countries
  • 10.5.1 Germany Market Forecast
  • 10.5.2 France Market Forecast
  • 10.5.3 UK Market Forecast
  • 10.5.4 Italy Market Forecast
  • 10.5.5 Russia Market Forecast
  • 10.5.6 Spain Market Forecast
• 10.6 Middle East & Africa Forecast by Countries
  • 10.6.1 Egypt Market Forecast
  • 10.6.2 South Africa Market Forecast
  • 10.6.3 Israel Market Forecast
  • 10.6.4 Turkey Market Forecast
  • 10.6.5 GCC Countries Market Forecast
• 10.7 Global Plerixafor Forecast by Type
• 10.8 Global Plerixafor Forecast by Application

11 Key Players Analysis

• 11.1 sanofi-aventis
  • 11.1.1 Company Details
  • 11.1.2 Plerixafor Product Offered
  • 11.1.3 sanofi-aventis Plerixafor Revenue, Gross Margin and Market Share (2017-2019)
  • 11.1.4 Main Business Overview
  • 11.1.5 sanofi-aventis News

...

12 Research Findings and Conclusion

Plerixafor (INN and USAN, trade name Mozobil) is an immunostimulant used to mobilize hematopoietic stem cells in cancer patients into the bloodstream.

According to this study, over the next five years the Plerixafor market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2024, from US$ xx million in 2019. In particular, this report presents the global revenue market share of key companies in Plerixafor business, shared in Chapter 3.

This report presents a comprehensive overview, market shares and growth opportunities of Plerixafor market by product type, application, key companies and key regions.

This study considers the Plerixafor value generated from the sales of the following segments:

Segmentation by product type: breakdown data from 2014 to 2019 in Section 2.3; and forecast to 2024 in section 10.7.
24MG/1.2ML
Type II
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 10.8.
Non-Hodgkin's lymphoma (NHL) Patients
Multiple myeloma (MM) Patients

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
sanofi-aventis
...

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key players and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives
To study and analyze the global Plerixafor market size by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Plerixafor market by identifying its various subsegments.
Focuses on the key global Plerixafor players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Plerixafor with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the size of Plerixafor submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.